|Bid||5.52 x 1400|
|Ask||5.62 x 1300|
|Day's Range||5.50 - 6.00|
|52 Week Range||5.50 - 11.59|
|Beta (5Y Monthly)||1.08|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 07, 2022 - Mar 11, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||17.95|
Investors need to pay close attention to Avadel (AVDL) stock based on the movements in the options market lately.
Every investor in Avadel Pharmaceuticals plc ( NASDAQ:AVDL ) should be aware of the most powerful shareholder groups...
DUBLIN, Ireland, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, announced today that Greg Divis, Chief Executive Officer of Avadel, will participate in the following upcoming investor conferences: Piper Sandler 33rd Annual Virtual Healthcare Conference: Participation starting on Monday, November 29 with a Fireside chat available for on-demand viewing starting today, Monday, November 22 at 10:00 a.m. ET.